Congenica Ltd.

https://www.congenica.com

Congenica is a digital health company enabling the rapid analysis and interpretation of genomic data, empowering researchers and clinicians to provide life-changing answers that improve wellbeing and disease management. Congenica's world-leading software enables rapid genomic data analysis at scale and is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive. A recognised leader in the genomic analysis of rare diseases and inherited cancer, Congenica is expanding its platform into new indications such as somatic cancer, next generation non- invasive pre-natal diagnosis and wellness, helping to deliver a future where clinical genomics is fully integrated into healthcare. Based on pioneering research from the Wellcome Sanger Institute and the UK NHS, Congenica has a global footprint supporting leading international laboratories, academic medical centres and biopharmaceutical companies and is the exclusive Clinical Decision Support partner for the NHS Genomic Medicine Service. *

	Start	2014-05-03 existent
	Group	Congenica (Group)
	Predecessor	Sanger Institute, The Wellcome Trust
	Industry	Sapientia™ clinical genomics analytics platform
	Industry 2	genomics
	Person	Denison, Robert (Rob) (Congenica 202206– CEO joined 201909 as Chief Information Officer)
	Person 2	Weaver, Tom (Congenica 201309– CEO before MRC + Source BioScience formerly Medical Solutions + Geneservice)

	Region	Hinxton, Cambridgeshire
	Country	United Kingdom (GB)
	Street	Wellcome Trust Genome Campus Wellcome Trust Genome Campus
	City	CB10 1DR Cambridge
	Tel	+44-1223-499965
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Congenica Ltd.. (8/4/22). "Press Release: GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution". Cambridge & Cleveland, OH.

		Record changed: 2023-06-26